Dexcom Inc (DXCM) Common Stock USD0.001

Sell:$88.76Buy:$88.81$0.56 (0.63%)

NASDAQ:2.20%
Market closed | Prices delayed by at least 15 minutes
Sell:$88.76
Buy:$88.81
Change:$0.56 (0.63%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$88.76
Buy:$88.81
Change:$0.56 (0.63%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.

Key people

Kevin R. Sayer
Chairperson of the Board, President, Chief Executive Officer
Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Jacob Steven Leach
Executive Vice President, Chief Operating Officer
Sadie M. Stern
Chief Human Resources Officer, Executive Vice President
Michael J. Brown
Executive Vice President, Chief Legal Officer
Matthew Vincent Dolan
Executive Vice President - Strategy, Corporate Development and Dexcom Labs
Mark G. Foletta
Lead Independent Director
Steven R. Altman
Independent Director
Nicholas Augustinos
Independent Director
Richard Alexander Collins
Independent Director
Karen M. Dahut
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US2521311074
  • Market cap
    $35.04bn
  • Employees
    10,300
  • Shares in issue
    408.97m
  • Exchange
    NASDAQ
  • Index
    S&P 500, NASDAQ 100 Index, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.